276 related articles for article (PubMed ID: 18811716)
1. A novel 2-hour method for rapid preparation of permanent paraffin sections when treating melanoma in situ with mohs micrographic surgery.
Mallipeddi R; Stark J; Xie XJ; Matthews M; Taylor RS
Dermatol Surg; 2008 Nov; 34(11):1520-6. PubMed ID: 18811716
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
[TBL] [Abstract][Full Text] [Related]
3. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
[TBL] [Abstract][Full Text] [Related]
4. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
Menaker GM; Chiang JK; Tabila B; Moy RL
J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
[TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
Bene NI; Healy C; Coldiron BM
Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
7. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers.
Barlow JO; Maize J; Lang PG
Dermatol Surg; 2007 Feb; 33(2):199-207. PubMed ID: 17300606
[TBL] [Abstract][Full Text] [Related]
8. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ.
Barlow RJ; White CR; Swanson NA
Br J Dermatol; 2002 Feb; 146(2):290-4. PubMed ID: 11903242
[TBL] [Abstract][Full Text] [Related]
9. Mohs frozen tissue sections in comparison to similar paraffin-embedded tissue sections in identifying perineural tumor invasion in cutaneous squamous cell carcinoma.
Green JS; Tournas JA; Allen EJ; Youker SR; Fosko SW
J Am Acad Dermatol; 2012 Jul; 67(1):113-21. PubMed ID: 22533992
[TBL] [Abstract][Full Text] [Related]
10. Special stains in Mohs surgery.
Miller CJ; Sobanko JF; Zhu X; Nunnciato T; Urban CR
Dermatol Clin; 2011 Apr; 29(2):273-86, ix. PubMed ID: 21421151
[TBL] [Abstract][Full Text] [Related]
11. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?
Prieto VG; Argenyi ZB; Barnhill RL; Duray PH; Elenitsas R; From L; Guitart J; Horenstein MG; Ming ME; Piepkorn MW; Rabkin MS; Reed JA; Selim MA; Trotter MJ; Johnson MM; Shea CR
Am J Clin Pathol; 2003 Aug; 120(2):203-8. PubMed ID: 12931550
[TBL] [Abstract][Full Text] [Related]
12. Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps Clinic.
Shumaker PR; Kelley B; Swann MH; Greenway HT
Dermatol Surg; 2009 Aug; 35(8):1263-70. PubMed ID: 19438663
[TBL] [Abstract][Full Text] [Related]
13. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
[TBL] [Abstract][Full Text] [Related]
14. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
15. Mohs surgery for melanoma in situ.
Kwon SY; Miller SJ
Dermatol Clin; 2011 Apr; 29(2):175-83, vii-viii. PubMed ID: 21421143
[TBL] [Abstract][Full Text] [Related]
16. Mohs surgery for the treatment of melanoma in situ: a review.
Dawn ME; Dawn AG; Miller SJ
Dermatol Surg; 2007 Apr; 33(4):395-402. PubMed ID: 17430372
[TBL] [Abstract][Full Text] [Related]
17. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
19. Mohs surgery for melanoma in situ: how we do it.
Cherpelis BS; Glass LF; Ladd S; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):786-8. PubMed ID: 20677533
[TBL] [Abstract][Full Text] [Related]
20. Imaging of Mohs micrographic surgery sections using full-field optical coherence tomography: a pilot study.
Durkin JR; Fine JL; Sam H; Pugliano-Mauro M; Ho J
Dermatol Surg; 2014 Mar; 40(3):266-74. PubMed ID: 24433402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
